SAB Biotherapeutics, Inc. - SABS

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q1 2026 · Q4 2025
Value (USD)
Total reported value ($000)
$272.6M
QoQ value delta ($000)
+$97.41M (+55.59%)
Implied price effect (QoQ)
-20.63%
Shares
Total shares
71,236,930
QoQ shares delta
+34,894,819 (+96.02%)
Total shares held by funds (by quarter)

Market chart (SABS)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q1 2026)

Top 25 only Full list
Partial Q1 2026 data: 79 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
Vivo Capital, LLC 43,738 11,420,000 3.64%
Caligan Partners LP 30,514 7,967,207 2.03%
PERCEPTIVE ADVISORS LLC 24,633 6,431,743 0.48%
RA CAPITAL MANAGEMENT, L.P. 16,857 4,401,500 0.18%
Commodore Capital LP 16,857 4,401,500 0.98%
BALYASNY ASSET MANAGEMENT L.P. 14,402 3,760,439 0.02%
ADAGE CAPITAL PARTNERS GP, L.L.C. 13,043 3,405,553 0.02%
MILLENNIUM MANAGEMENT LLC 11,615 3,032,697 0.0%
Woodline Partners LP 10,922 2,851,791 0.04%
VANGUARD CAPITAL MANAGEMENT LLC 9,551 2,493,737 0.0%
Sessa Capital IM, L.P. 8,420 2,198,457 0.15%
Spruce Street Capital LP 8,420 2,198,502 2.02%
VANGUARD GROUP INC 6,908 1,847,136 0.0%
BOOTHBAY FUND MANAGEMENT, LLC 5,674 1,481,660 0.07%
AMERIPRISE FINANCIAL INC 5,653 1,476,106 0.0%
Ensign Peak Advisors, Inc 5,268 1,375,610 0.01%
Soleus Capital Management, L.P. 4,021 1,050,000 0.16%
Propel Bio Management, LLC 3,886 1,012,790 2.45%
Jefferies Financial Group Inc. 3,458 903,094 0.02%
Blackstone Inc. 3,294 860,170 0.01%
ExodusPoint Capital Management, LP 2,943 768,627 0.02%
Affinity Asset Advisors, LLC 2,202 575,000 0.11%
Monashee Investment Management LLC 1,915 500,000 1.04%
MARSHALL WACE, LLP 1,776 463,925 0.0%
AWM Investment Company, Inc. 1,532 400,000 0.17%